Barinthus Biotherapeutics plc
BRNS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $50,826 | $37,524 | $39,166 | $47,611 |
| - Cash | $74,272 | $86,259 | $99,118 | $110,662 |
| + Debt | $11,570 | $11,988 | $11,919 | $12,007 |
| Enterprise Value | -$11,876 | -$36,747 | -$48,033 | -$51,044 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$13,428 | -$19,138 | -$17,633 | -$19,148 |
| % Margin | – | – | – | – |
| Net Income | -$14,566 | -$21,124 | -$19,648 | -$20,540 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.36 | -0.52 | -0.49 | -0.51 |
| % Growth | 30.8% | -6.1% | 3.9% | – |
| Operating Cash Flow | -$10,726 | -$18,109 | -$14,902 | $13,086 |
| Capital Expenditures | $0 | -$32 | -$5 | -$278 |
| Free Cash Flow | -$10,726 | -$18,141 | -$14,907 | $12,808 |